GET THE APP

Exploring the anti-seizure potential of selective PI3K inhibitor in zebrafish model of pentylenetetrazole induced seizure
..

Neurological Disorders

ISSN: 2329-6895

Open Access

Exploring the anti-seizure potential of selective PI3K inhibitor in zebrafish model of pentylenetetrazole induced seizure


Joint Event on 4th International Conference on Epilepsy & Treatment & 4th World Congress on Parkinsons & Huntington Disease

August 29-30, 2018 | Zurich, Switzerland

Arindam Ghosh Mazumder and Damanpreet Singh

CSIR-Institute of Himalayan Bioresource Technology, India

Scientific Tracks Abstracts: J Neurol Disord

Abstract :

The role of mammalian target of rapamycin (mTOR), an evolutionary serine/threonine protein kinase, has been well documented in several disorders. In epilepsy research, mTOR pose as a very exhilarating target, as inhibition of its hyperactivation has been found to be effective in suppression of epilepsy and epileptogenesis. However the precise mechanism for the aberrant expression of mTOR, leading to the overexpression of its downstream genes, still remains blurred. Preclinical and clinical studies have revealed that decrease in PI3K/AKT/mTOR pathway hyperactivation have considerably reduced seizures. Hence, our study was designed to explore the anti-seizure potential of selective PI3K inhibitor (morpholine containing compound) on zebrafish model of pentylenetetrazole induced seizure. Zebrafish larvae of 7 days post fertilization were subjected to different concentrations of the selective PI3K inhibitor, following which they were exposed to pentylenetetrazole and recordings were scored on a 3 point scale. The best therapeutic concentration was selected and it was tested on adult zebrafish. Furthermore, fish brains were isolated and expressions of genes were studied in comparison to the epileptic fish. The results showed that the inhibitor distinctly reduced the seizure state in both larvae and adult fish in combination to decreasing the expression of various genes of the PI3K/AKT/mTOR pathway. These findings concluded that selective PI3K inhibitor has anti-seizure potential and can be explored in the near future as a potential antiepileptic.

Biography :

Arindam Ghosh Mazumder is a Senior Research Fellow, currently pursuing his PhD from CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India. He was awarded DST-INSPIRE Fellowship for pursuing PhD, sponsored by the Department of Science and Technology (DST), Government of India, 2013.

E-mail: agmazumder08@gmail

 

Google Scholar citation report
Citations: 1253

Neurological Disorders received 1253 citations as per Google Scholar report

Neurological Disorders peer review process verified at publons

Indexed In

arrow_upward arrow_upward